Myoclonus in patients with COVID-19: Findings of autoantibodies against brain structures in cerebrospinal fluid.
Eur J Neurol
; 30(10): 3142-3148, 2023 10.
Article
em En
| MEDLINE
| ID: mdl-37392418
ABSTRACT
BACKGROUND AND PURPOSE:
COVID-19 is associated with multiple neurological manifestations. The clinical presentation, trajectory, and treatment response for three cases of myoclonus during COVID-19 infection, with no previous neurological disease, are decsribed. METODS Analysis of cerebrospinal fluid from the cases using indirect immunohistochemistry.RESULTS:
Antibodies against rodent brain tissue, and similarities in staining patterns were observed, indicating the presence of antineuronal immunoglobulin G autoantibodies targeting astrocytes in the hippocampus.CONCLUSION:
Our results demontrate cerebrospinal fluid antineuronal antibodies indicating an an autoimmune involvment in the pathogenesis in COVID-19 associated myoclonus.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Mioclonia
/
Doenças do Sistema Nervoso
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
Limite:
Humans
Idioma:
En
Revista:
Eur J Neurol
Assunto da revista:
NEUROLOGIA
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Suécia